Clinical trial
Facial Lipoatrophy Correction Experience With SCULPTRA ("FACES" Study)
NCT00360932 · Bausch Health Americas, Inc., Industry · Completed
Key facts
| NCT number | NCT00360932 |
|---|---|
| Title | Facial Lipoatrophy Correction Experience With SCULPTRA ("FACES" Study) |
| Official title | An Open-Label Registry Study of the Facial Lipoatrophy Correction Experience With SCULPTRA® in Subjects With Human Immunodeficiency Virus (FACES Study) |
| Acronym | FACES |
| Lead sponsor | Bausch Health Americas, Inc., Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Facial Lipoatrophy |
| Intervention type | Device |
| Interventions | SCULPTRA (poly-L-lactic acid injection) |
| Enrollment | 290 |
| Start date | Oct 1, 2005 |
| Primary completion | Aug 1, 2011 |
| Completion | Aug 1, 2011 |
| First posted | Aug 7, 2006 |
| Last update posted | Sep 18, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: